Page 1861 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

4 References

112. Klein-Schwartz W, Doyon S. Intravenous acetylcysteine 133. Barceloux DG, Krenzelok EP, Olson K, et al. American Academy
for the treatment of acetaminophen overdose. Expert Opin of Clinical Toxicology Practice Guidelines on the Treatment of
Pharmacother. 2011;12:119-130. Ethylene Glycol Poisoning. Ad Hoc Committee. J Toxicol Clin
113. Woo OF, Mueller PD, Olson KR, et al. Shorter duration of oral Toxicol. 1999;37:537-560.
N-acetylcysteine therapy for acute acetaminophen overdose. 134. Brent J. Fomepizole for ethylene glycol and methanol poisoning.
Ann Emerg Med. 2000;35:363-368. N Engl J Med. 2009;360:2216-2223.
114. Prescott LF, Illingworth RN, Critchley JA, et al. Intravenous 135. Buchanan JA, Alhelail M, Cetaruk EW, et al. Massive ethylene
N-acetylcystine: the treatment of choice for paracetamol glycol ingestion treated with fomepizole alone-a viable thera-
poisoning. Br Med J. 1979;2:1097-1100. peutic option. J Med Toxicol. 2010;6:131-134.
115. Smilkstein MJ, Bronstein AC, Linden C, et al. Acetaminophen 136. McCoy HG, Cipolle RJ, Ehlers SM, et al. Severe methanol
overdose: a 48-hour intravenous N-acetylcysteine treatment poisoning. Application of a pharmacokinetic model for ethanol
protocol. Ann Emerg Med. 1991;20:1058-1063. therapy and hemodialysis. Am J Med. 1979;67:804-807.
116. Martello JL, Pummer TL, Krenzelok EP. Cost minimization 137. Peterson CD, Collins AJ, Himes JM, et al. Ethylene glycol
analysis comparing enteral N-acetylcysteine to intravenous ace- poisoning: pharmacokinetics during therapy with ethanol and
tylcysteine in the management of acute acetaminophen toxicity. hemodialysis. N Engl J Med. 1981;304:21-23.
Clin Toxicol (Phila). 2010;48:79-83. 138. Sabeel AI, Kurkus J, Lindholm T. Intensified dialysis treat-
117. Mutimer DJ, Ayres RC, Neuberger JM, et al. Serious ment of ethylene glycol intoxication. Scand J Urol Nephrol.
paracetamol poisoning and the results of liver transplantation. 1995;29:125-129.
Gut. 1994;35:809-814. 139. Schep LJ, Slaughter RJ, Temple WA, et al. Diethylene glycol
118. O’Grady JG, Alexander GJ, Hayllar KM, et al. Early indicators poisoning. Clin Toxicol (Phila). 2009;47:525-535.
of prognosis in fulminant hepatic failure. Gastroenterology 140. Lacouture PG, Wason S, Abrams A, et al. Acute isopropyl
1989;97:439-445. alcohol intoxication. Diagnosis and management. Am J Med.
119. Mitchell I, Bihari D, Chang R, et al. Earlier identification of 1983;75:680-686.
patients at risk from acetaminophen-induced acute liver failure. 141. Substance Abuse and Mental Health Services Administration.
Crit Care Med. 1998;26:279-284. Results from the 2009 National Survey on Drug Use and Health:
120. Jacobsen D, McMartin KE. Antidotes for methanol and ethylene Volume I. Summary of National Findings (Office of Applied
glycol poisoning. J Toxicol Clin Toxicol. 1997;35:127-143. Studies, NSDUH Series H-38A, HHS Publication No. SMA
10-4856Findings). Rockville, MD. 2010.
121. Gabow PA. Ethylene glycol intoxication. Am J Kidney Dis.
1988;11:277-279. 142. Jones AL, Simpson KJ. Review article: mechanisms and man-
agement of hepatotoxicity in ecstasy (MDMA) and amphet-
122. Krenzelok EP, Leikin JB. Approach to the poisoned patient. Dis amine intoxications. Aliment Pharmacol Ther. 1999;13:129-133.
Mon. 1996;42:509-607.
143. Watson JD, Ferguson C, Hinds CJ, et al. Exertional heat stroke
123. Curtin L, Kraner J, Wine H, et al. Complete recovery after induced by amphetamine analogues. Does dantrolene have a
massive ethylene glycol ingestion. Arch Intern Med. 1992;152: place? Anaesthesia. 1993;48:1057-1060.
1311-1313.
144. Denborough MA, Hopkinson KC. Dantrolene and “ecstasy”.
124. Palmer BF, Eigenbrodt EH, Henrich WL. Cranial nerve deficit: Med J Aust. 1997;166:165-166.
a clue to the diagnosis of ethylene glycol poisoning. Am J Med.
1989;87:91-92. 145. Grunau BE, Wiens MO, Brubacher JR. Dantrolene in the treat-
ment of MDMA-related hyperpyrexia: a systematic review.
125. Mallya KB, Mendis T, Guberman A. Bilateral facial paralysis CJEM. 2010;12:435-442.
following ethylene glycol ingestion. Can J Neurol Sci. 1986;13: 146. Sutherland GR, Park J, Proudfoot AT. Ventilation and acid-base
340-341.
changes in deep coma due to barbiturate or tricyclic antidepres-
126. Kruse JA. Methanol poisoning. Intensive Care Med. 1992;18: sant poisoning. Clin Toxicol. 1977;11:403-412.
391-397.
147. Raymond LW. “Barbiturate blisters” in a case of severe hypogly-
127. Hantson P, Mahieu P. Pancreatic injury following acute metha- caemic coma. Lancet. 1972;2:764.
nol poisoning. J Toxicol Clin Toxicol. 2000;38:297-303.
148. Boldy DA, Vale JA, Prescott LF. Treatment of phenobarbitone
128. Brent J. Current management of ethylene glycol poisoning. poisoning with repeated oral administration of activated char-
Drugs. 2001;61:979-988. coal. Q J Med. 1986;61:997-1002.
129. Megarbane B, Borron SW, Baud FJ. Current recommendations 149. Goldberg MJ, Berlinger WG. Treatment of phenobarbital over-
for treatment of severe toxic alcohol poisonings. Intensive Care dose with activated charcoal. JAMA. 1982;247:2400-2401.
Med. 2005;31:189-195. 150. Berg MJ, Berlinger WG, Goldberg MJ, et al. Acceleration of
130. Brent J, McMartin K, Phillips S, et al. Fomepizole for the treat- the body clearance of phenobarbital by oral activated charcoal.
ment of ethylene glycol poisoning. Methylpyrazole for Toxic N Engl J Med. 1982;307:642-644.
Alcohols Study Group. N Engl J Med. 1999;340:832-838. 151. Mohammed Ebid AH, Abdel-Rahman HM. Pharmacokinetics
131. Brent J, McMartin K, Phillips S, et al. Fomepizole for the treat- of phenobarbital during certain enhanced elimination modali-
ment of methanol poisoning. N Engl J Med. 2001;344:424-429. ties to evaluate their clinical efficacy in management of drug
132. Barceloux DG, Bond GR, Krenzelok EP, et al. American Academy overdose. Ther Drug Monit. 2001;23:209-216.
of Clinical Toxicology practice guidelines on the treatment of 152. Costello JB, Poklis A. Treatment of massive phenobarbital over-
methanol poisoning. J Toxicol Clin Toxicol. 2002;40:415-446. dose with dopamine diuresis. Arch Intern Med. 1981;141:938-940.

Section11-O-Ref.indd 4 12/10/2014 8:08:24 PM